Interactions Between the Heart and Cancer
Technion Researchers reveal complex interactions between heart disease and cancer, in the hope that their findings will lead to improved treatment for both conditions.
News
Tiny Windows into a Vast Future
According to researchers at the Technion – Israel Institute of Technology, the future of energy lies in technological breakthroughs in porous materials, whose influence extends across diverse fields – from computing systems to biomedical engineering. Published in Science, their findings present a long-term roadmap for the evolution of the energy sector.
PRESS RELEASE: Technion Australia Hosts Einstein Supper in Melbourne on the True Cost of the Net Zero Transition
Technion Australia’s Einstein Supper in Melbourne explored the true environmental, material, and financial costs of Australia’s net-zero transition, featuring expert insights from Dr Rod Hill.
Where Should You Study for a Successful Career? At the Technion, of Course
Thinking about where to study for a thriving career? Discover why the Technion stands out: leading‑edge programs, real‑world innovation, and access to global opportunities that help ambitious students succeed.
Technion Awards Harvey Prize to Two American Pioneers in Nanotech and Medicine
The Technion has awarded the Harvey Prize to two leading American scientists whose breakthroughs in nanotechnology and medicine are shaping the future of global research and innovation.
PRESS RELEASE: Technion Australia Ignites Innovation and Identity at Moriah College Hackathon
Technion Australia joined forces with Moriah College for a groundbreaking hackathon that blended high-tech innovation with Jewish identity – empowering students to build meaningful tech solutions and forge deeper ties to Israel.
A Model of Generosity
The Ruth and Bruce Rappaport Faculty of Medicine inaugurated a new complex for its Teaching and Medical Education Division, established through the generous contribution of Professor Emeritus John Finberg — one of the faculty’s veterans and a co-developer of the first-ever drug shown to slow the progression of Parkinson’s disease.
Former German Chancellor Dr. Angela Merkel Visits the Technion
Former German Chancellor Dr Angela Merkel visited the Technion, meeting students and researchers, touring key labs, and highlighting the deep scientific partnership between Israel and Germany.
Technion Scientists Create Next-Gen “Smart Glue” for Wounds
Technion scientists unveil a fast-acting bio-glue that bonds wet tissues in seconds—reducing bleeding, infections and the need for stitches.
Technion Receives Grants for Heart and Diabetes Studies
The Technion has been awarded 5.75 million NIS in Mavri grants to develop engineered tissues aimed at heart rehabilitation and improving treatments for juvenile diabetes.
Biofilm Takes Flight: How Bacteria Survive through Dust Storm Events
In a groundbreaking study, Technion researchers discovered that Bacillus bacteria form protective biofilms within desert dust particles, allowing them to endure extreme conditions during transport from the Sahara and Egypt to Israel. This finding sheds light on the resilience of microbial life and its potential impact on global ecosystems.
Technion Launches a New Program for International Students
Amid rising antisemitism abroad, the Technion has launched a pioneering program welcoming 26 students from eight countries. With English instruction, Hebrew ulpan, mentorship, and academic support, it offers a safe, world-class path to degree studies in Israel.